Ondine Biomedical (UK) Performance
| OBI Stock | 8.00 0.13 1.60% |
On a scale of 0 to 100, Ondine Biomedical holds a performance score of 4. The company holds a Beta of 1.07, which implies a somewhat significant risk relative to the market. Ondine Biomedical returns are very sensitive to returns on the market. As the market goes up or down, Ondine Biomedical is expected to follow. Please check Ondine Biomedical's total risk alpha, value at risk, and the relationship between the standard deviation and treynor ratio , to make a quick decision on whether Ondine Biomedical's historical price patterns will revert.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Ondine Biomedical are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Ondine Biomedical exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Ondine Biomedical Inc Announces Notice of Results, Investor Presentation, and AGM - Yahoo Finance UK | 09/04/2024 |
2 | Ondine Secures C5 million Financing - Yahoo Finance UK | 09/24/2024 |
3 | Ondine Continues Commercial Growth - AccessWire | 10/28/2024 |
4 | Ondine Biomedical Increases Fundraising Efforts - TipRanks | 11/13/2024 |
| Begin Period Cash Flow | 13.3 M |
Ondine |
Ondine Biomedical Relative Risk vs. Return Landscape
If you would invest 700.00 in Ondine Biomedical on August 30, 2024 and sell it today you would earn a total of 100.00 from holding Ondine Biomedical or generate 14.29% return on investment over 90 days. Ondine Biomedical is generating 0.3788% of daily returns and assumes 6.2814% volatility on return distribution over the 90 days horizon. Simply put, 55% of stocks are less volatile than Ondine, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Ondine Biomedical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ondine Biomedical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Ondine Biomedical, and traders can use it to determine the average amount a Ondine Biomedical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0603
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | OBI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.28 actual daily | 55 55% of assets are less volatile |
Expected Return
| 0.38 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Ondine Biomedical is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ondine Biomedical by adding it to a well-diversified portfolio.
Ondine Biomedical Fundamentals Growth
Ondine Stock prices reflect investors' perceptions of the future prospects and financial health of Ondine Biomedical, and Ondine Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ondine Stock performance.
| Return On Equity | -6.86 | ||||
| Return On Asset | -1.6 | ||||
| Operating Margin | (9.12) % | ||||
| Current Valuation | 33.61 M | ||||
| Shares Outstanding | 426.23 M | ||||
| Price To Book | 3,171 X | ||||
| Price To Sales | 20.87 X | ||||
| Revenue | 1.2 M | ||||
| Gross Profit | 1.25 M | ||||
| EBITDA | (14.12 M) | ||||
| Net Income | (14.41 M) | ||||
| Total Debt | 541 K | ||||
| Cash Flow From Operations | (13.65 M) | ||||
| Earnings Per Share | (0.03) X | ||||
| Total Asset | 5.73 M | ||||
| Retained Earnings | (266.33 M) | ||||
About Ondine Biomedical Performance
By analyzing Ondine Biomedical's fundamental ratios, stakeholders can gain valuable insights into Ondine Biomedical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ondine Biomedical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ondine Biomedical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ondine Biomedical is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about Ondine Biomedical performance evaluation
Checking the ongoing alerts about Ondine Biomedical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ondine Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ondine Biomedical had very high historical volatility over the last 90 days | |
| Ondine Biomedical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.2 M. Net Loss for the year was (14.41 M) with profit before overhead, payroll, taxes, and interest of 1.25 M. | |
| Ondine Biomedical generates negative cash flow from operations | |
| About 47.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Ondine Biomedical Increases Fundraising Efforts - TipRanks |
- Analyzing Ondine Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ondine Biomedical's stock is overvalued or undervalued compared to its peers.
- Examining Ondine Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ondine Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ondine Biomedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ondine Biomedical's stock. These opinions can provide insight into Ondine Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ondine Stock analysis
When running Ondine Biomedical's price analysis, check to measure Ondine Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ondine Biomedical is operating at the current time. Most of Ondine Biomedical's value examination focuses on studying past and present price action to predict the probability of Ondine Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ondine Biomedical's price. Additionally, you may evaluate how the addition of Ondine Biomedical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |